GAMMA Investing’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Buy |
726
+110
| +18% | +$35.9K | 0.02% | 803 |
|
|
2025
Q1 | $166K | Buy |
616
+77
| +14% | +$20.8K | 0.01% | 874 |
|
|
2024
Q4 | $127K | Sell |
539
-15
| -3% | -$3.53K | 0.01% | 945 |
|
|
2024
Q3 | $152K | Buy |
554
+138
| +33% | +$38K | 0.02% | 750 |
|
|
2024
Q2 | $101K | Buy |
416
+205
| +97% | +$49.8K | 0.01% | 775 |
|
|
2024
Q1 | $31.5K | Sell |
211
-59
| -22% | -$8.82K | 0.01% | 1331 |
|
|
2023
Q4 | $46.7K | Buy |
+270
| New | +$46.7K | 0.01% | 932 |
|